Nyxoah Sets July 8 New York Investor Day to Review Q2 Genio KPIs
NYXH•Nyxoah will host an Investor Day on July 8, 2026, in New York to review Q2 U.S. commercial KPIs for its Genio OSA system and outline U.S. reimbursement strategy and path to profitability. The 10 AM–12:30 PM ET event at Bank of America Tower includes a live webcast with Q&A.
1. Event Logistics
Nyxoah’s Investor and Analyst Day will take place on July 8, 2026, from 10 AM to 12:30 PM ET at the Bank of America Tower in New York. A live webcast with interactive Q&A will be available for remote participants.
2. Agenda Highlights
The leadership team and Board will present Q2 U.S. commercial performance metrics for the Genio system, assess U.S. reimbursement dynamics with JD Lymon Group, and outline the company’s framework for disciplined growth, capital efficiency and operating leverage.
3. Featured Presenters
Nyxoah’s executive team, including Chairman Robert Taub and CEO Olivier Taelman, will be joined by clinical experts Andrew T. Huang, MD, and Vikas Jain, MD, as well as reimbursement specialists from JD Lymon Group.
